|
 |
| RESEARCH ARTICLE |
|
|
|
| Year : 2016 | Volume
: 48
| Issue : 1 | Page : 64-68 |
| |
Cytotoxic potential of few Indian fruit peels through 3-(4,5-dimethylthiazol-yl)-2,5-diphenyltetrazolium bromide assay on HepG2 cells
Munish Garg, Kusum Lata, Saurabh Satija
Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India
| Date of Submission | 24-Aug-2015 |
| Date of Decision | 14-Dec-2015 |
| Date of Acceptance | 30-Dec-2015 |
| Date of Web Publication | 20-Jan-2016 |
Correspondence Address:
Munish Garg
Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.174552
Objective: To investigate in vitro anticancer activity of a few Indian fruit peels through 3-(4,5-dimethylthiazol-yl)-2,5-diphenyltetrazolium bromide (MTT) assay against HepG2 cells.
Materials and Methods: Hydroalcoholic extracts were prepared of five fruit peels, i.e., banana, lemon, guava, orange, and papaya by maceration and thereafter subjected for MTT assay to evaluate anticancer potential on HepG2 cells. Plant extract showed best activity was further fractionated with petroleum ether, chloroform, and ethyl acetate successively and screened again. Phytochemical analysis was then carried out to find out responsible components for the observed activity.
Results: Out of the 40 samples from five fruit peel extracts with rich folklore usage, papaya extract showed maximum activity with least inhibitory concentration 50 (IC 50 ) value of 18.5 μg/ml. Further analysis after fractionation of the papaya peel extract, aqueous fraction showed the maximum inhibitory activity with least IC 50 value of 17.3 μg/ml. Phytochemical analysis of the aqueous fraction of papaya peel extract revealed the presence of flavonoids and glycosides. Total flavonoid content found to be 72.25 mg/g.
Conclusion: Papaya fruit extract demonstrated the best activity against MTT assay which may be due to the presence of flavonoids.
Keywords: 3-(4,5-dimethylthiazol-yl)-2,5-diphenyltetrazolium bromide assay, Anticancer activity, Carica papaya, fruit peels
How to cite this article:
Garg M, Lata K, Satija S. Cytotoxic potential of few Indian fruit peels through 3-(4,5-dimethylthiazol-yl)-2,5-diphenyltetrazolium bromide assay on HepG2 cells. Indian J Pharmacol 2016;48:64-8 |
How to cite this URL:
Garg M, Lata K, Satija S. Cytotoxic potential of few Indian fruit peels through 3-(4,5-dimethylthiazol-yl)-2,5-diphenyltetrazolium bromide assay on HepG2 cells. Indian J Pharmacol [serial online] 2016 [cited 2023 Oct 1];48:64-8. Available from: https://www.ijp-online.com/text.asp?2016/48/1/64/174552 |
| » Introduction | |  |
Cancer is a hyperproliferative disorder which involves transformation, dysregulation of apoptosis, proliferation, invasion, angiogenesis, and metastasis. Malignant cancer is the second leading cause of death worldwide killing about 3.5 million people annually all over the world. Multidisciplinary scientific research attempts are making the best efforts to combat this dreadful disease, but the sure-shot, perfect cure is yet to be brought into medicinal world. [1] There is a continuing need for development of new anticancer drugs through methodical and scientific exploration of the enormous pool of synthetic, biological, and natural products. [2] As the conventional cancer therapies failed to fulfill the criteria for a successful cancer therapy, recent research revolves around the urgency to develop suitable chemotherapy for the treatment of cancer with no toxic effects. [3] It was reported that cancer therapies utilizing the natural products like plants is a relatively new but very promising strategy in preventing cancer. [4] Plant-derived natural products such as flavonoids, alkaloids and terpenes have received significant attention in the recent years due to their diverse pharmacological properties including cytotoxic and cancer chemo preventive effects. [5] In light of the high need for effective anticancer agents, and the association of fruit and vegetable consumption with reduced cancer risk, edible plants are increasingly being considered as sources of anticancer drugs and is regarded as one of the most visible fields for cancer control. [6],[7]
Nature is an attractive source of new therapeutic candidate compounds as a huge chemical diversity is found in millions of species of plants, animals, marine organisms, and microorganisms as potential anticancer agents. A large number of plant-derived compounds have been identified for prevention and treatment of cancer, such as paclitaxel, vinblastine, camptothecin, resveratrol, melatonin, sulforaphane, genistein, brassinin, and lycopene. [8]
Fruit peels are the protective coverings of the fruits which are generally considered as a waste material and are discarded after fruits consumption but many recent investigations have proved that these fruit peels may contain many bioactive constituents which have various significant medicinal and pharmacological properties. [9],[10] On the basis of this background, we aimed to investigate the in vitro anticancer potential of five Indian fruit peels through 3-(4,5-dimethylthiazol-yl)- 2,5-diphenyltetrazolium bromide (MTT) assay on HepG2 cells since no such work has been carried out so far.
| » Materials and Methods | | |
Selection of Fruits
The traditional fruits were collected from local market of Rohtak, Haryana (India). Five fruits were selected on the basis of various ethnopharmacological reports and investigations as anticancer potential or similar activities of these fruits. The selected fruits are mentioned below in [Table 1]. | Table 1: List of fruit peels to be evaluated for the anticancer activity
Click here to view |
Preparation of Extracts
100 g of dried, powdered fruit peels of each fruit were subjected for maceration for 7 days using ethanol: water (80:20) as a solvent. The mixture was shaken at regular intervals. The resultant extracts were then filtered and concentrated to remove the solvent and dried completely by lyophilisation. The dried extracts were suspended in water for the cytotoxic assay.
Cell Lines Used
Human HepG2 hepatocellular carcinoma (HCC) cell lines were procured from National Centre for Cell Science, Department of Biotechnology, Government of India, Pune, Maharashtra, India.
In vitro Assay for Cytotoxic Activity 3-(4,5-dimethylthiazol-yl)-2,5-diphenyltetrazolium bromide Assay
The cytotoxicity of all the extracts was determined by a tetrazolium (MTT) assay. [6] HepG2 cells were plated (Bioklenz laminar air flow) onto 96 well plates on a cell density of 2 × 10 5 /ml per well in 100 μl of RPMI 1640 and allowed to grow in a CO 2 incubator (New Bruswick Galaxy 170S) for 24 h (37°C, 5% CO 2 ). The medium was then replaced by fresh medium containing different concentrations of the sample (5, 10, 20, 40, and 80 μg/ml) for further 48 h incubation. Then 20 μl MTT stock solution (5 mg/ml in phosphate-buffered solution) was added to each well and incubated for 5 h. The medium was removed, and 200 μl DMSO was added to each well to dissolve the MTT metabolic product. The absorbance was measured at 560 nm by ELISA reader. Percentage viability of samples was calculated using the formula:
% cytoviability = A 560 of treated cells/A 560 of control cells × 100%.
The percentage viability was plotted against concentration and linear regression curve were established in order to calculate inhibitory concentration 50 (IC 50 ) values of the extracts in order to determine their efficacy. IC 50 value represents the concentration of a sample (μg/ml) necessary to inhibit 50% of cells.
Fractionation and Further Analysis
Extract with least IC 50 value was fractionated with petroleum ether, ethyl acetate, and chloroform to obtain the respective fractions. The aqueous fraction was obtained as the remaining fraction. These fractions were suspended in water, and MTT assay was carried out. The preliminary phytochemical screening was carried out by chemical tests to determine the presence/absence of major phytoconstituents. Total flavonoid content was estimated using standard method as rutin equivalent.
| » Results | | |
Extraction
The selected fruit peels for the present study were extracted and fractionated as detailed. The extractive value of each fruit peel extract is presented in [Table 2].
3-(4,5-dimethylthiazol-yl)-2,5-diphenyltetrazolium bromide Assay for Peel Extracts
MTT assay was carried out for each extract against HepG2 cells. The regression graphs plotted for calculation of IC 50 values are represented in [Figure 1] and [Figure 2]. The results reveal that out of observed IC 50 values of all extracts, papaya has shown best activity with least IC 50 value of 18.5 μg/ml [Table 3]. Further, the fractionation of papaya peel extract was carried out with petroleum ether, ethyl acetate, and chloroform successively and the remaining fraction was considered as an aqueous fraction. | Figure 1: Regression graphs for inhibitory concentration50 value (a) banana peel extract (b) lemon peel extract (c) orange peel extract
Click here to view |
 | Figure 2: Regression graphs for inhibitory concentration50 value (a) guava peel extract (b) papaya peel extract
Click here to view |
3-(4,5-dimethylthiazol-yl)-2,5-diphenyltetrazolium bromide Assay for Fractions of Papaya Peel Extract
The fractionation of the papaya peel extract was carried out with petroleum ether, ethyl acetate, and chloroform successively and the remaining fraction was considered as an aqueous fraction. The MTT assay as described above was again performed on four fractions of papaya fruit peel extract and IC 50 [Table 4] values were determined. The regression graphs plotted for calculation of IC 50 values are represented in [Figure 3]. | Figure 3: Regression graphs for inhibitory concentration50 value different fractions of papaya peel extract (a) ethyl acetate fraction (b) chloroform fraction (c) aqueous fraction
Click here to view |
 | Table 4: Extractive values and inhibitory concentration50 values of the fractions of the papaya peel extract
Click here to view |
Phytochemical Screening of Papaya Peels Extract
Preliminary phytochemical analysis
Preliminary phytochemical analysis of papaya peel extracts showed the presence of carbohydrates, proteins, flavonoids, which are enlisted in [Table 5]. The value for total flavonoid content is depicted in [Table 6]. | Table 5: Tests performed for the detection of compounds and their inference
Click here to view |
 | Table 6: Percentage flavonoid content of aqueous fraction of Carica papaya peels
Click here to view |
| » Discussion | | |
The last two decades have witnessed a clear global inclination for drugs and health foods from natural resources. With the realization of health hazards and toxicity associated with the indiscriminate use of synthetic drugs and remedies, introduction of postmarketing surveillance and active adverse drug reaction monitoring, more than ever a need has been felt for an integrated system of medicine which would minister to the human body as a whole, safety being a major concern. The solution may perhaps be hidden into the traditional system of medicines such as "Ayurveda" or the "Science of life" Fruit peels considered as waste part of the total fruit, contain many bioactive constituents which are responsible for several potential pharmacological and medicinal properties. Scientific studies conducted in the recent past have concluded that fruits and fruit peels rich in phenolics and flavonoids have shown significant antioxidant and anticancer activities. [9],[11] Many fruits such as guava, banana, papaya, orange, lemon, apple, litchi possess proven medicinal activities as whole fruit, seeds, leaves, and as peels [12],[13],[14] and many of them are reported to have anticancer potential such as lemon, [15] orange, [16] papaya, [17] guava. [18] On the basis of this, a step was taken forward to evaluate the anticancer potential of five Indian fruit peels. Since cultured cancer cells are valuable reagents for rapid screening of potential anticancer agents as well as for elucidating the mechanism of their activity so this procedure was used in the present study.
HCC is one of the most common malignancies, responsible for an estimated one million deaths annually. [19] Therefore, it becomes important to discover new agents which are effective on growth inhibition of HCC. Taking this into consideration, the present study was conducted on HepG2 cell lines. HepG2 are adherent, epithelial-like cells growing as monolayers and in small aggregates, have a model chromosome number of 55. HepG2 cell line was derived from the liver tissues. These HepG2 cell lines have previously been used for evaluation of the cytotoxic potential of fruit extracts. [20] As in the present study, five fruit peel extracts, i.e., banana, guava, orange, lemon, and papaya were assessed for the anticancer activity against HepG2 human liver cancer cells. The hydroalcoholic extracts of the fruit peels were prepared by maceration for 7 days in ethanol: water (80:20). The anticancer activity was carried out by MTT assay. The extracts of banana, guava, orange and papaya showed good anticancer activity with IC 50 values 31.7, 27, 95.5, and 18.5 μg/ml, respectively. Among these papaya extract exhibited the best anticancer activity as evidence from IC 50 values. Various fruit extracts have already been previously reported to have anticancer properties such as cranberry, lemon, apple, strawberry, red grape, banana, and grapefruit that showed potent antiproliferative activity toward the HepG2 cell line, [21] rowanberry, raspberry, lingonberry, cloudberry, arctic bramble, and strawberry towards HeLa (human cervical cancer). [22] The Lemon peel and Orange peel extract did not show significant anticancer activity. The Lemon peel and orange peel extracts do not possess significant anti-tumor properties as evident from previously reported study. [23],[24] The papaya peel extract was selected for further study. Various fractions (petroleum ether, ethyl acetate, chloroform, and water) of the papaya peel extract were prepared by liquid-liquid partitioning, and these fractions were then subjected to the anticancer study by MTT assay against the HepG2 cell lines. The IC 50 values of various fractions were: Ethyl acetate - 18.0 μg/ml, chloroform - 25.0 μg/ml, and aqueous fraction - 17.3 μg/ml. Petroleum ether fraction did not reveal any significant results.
Though MTT is not the only sure and certain method for evaluation of anticancer activities, it is only a step to check the cytotoxicity of the sample toward cancer cell lines and hints that the sample may have the anticancer activity which can be confirmed by other assays such as XTT, trypan blue dye exclusion followed by in vivo studies and clinical trials which in this regard is also worth investigation. [17],[25] Papaya has shown anticancer activities in some previously conducted study; [25] moreover, several studies have proved that flavonoids are responsible for the anticancer properties present in many fruits. [9],[26] Based on this, it can be said that fruit may peels may possess anticancer potential against HCC, particularly papaya fruit peels.
| » Conclusion | | |
The aqueous papaya peel extract conferred noticeable cytotoxicity against the prostate and HepG2 cancer cell lines supporting toward its development as a potential therapeutic agent for the treatment of cancer with further insight toward the possible mechanisms of actions. This is the first report on the cytotoxic potential of the peels of Carica papaya, and the results obtained strongly provide support for the ethnobotanical use of the fruit.
Financial Support and Sponsorship
Nil.
Conflicts of Interest
There are no conflicts of interest.
| » References | | |
| 1. | Sharma T, Rawal G. Role of ayurveda in tumorigenesis: A brief review. Int J Green Pharm 2012;6:93-101.   |
| 2. | Mukherjee AK, Basu S, Sarkar N, Ghosh AC. Advances in cancer therapy with plant based natural products. Curr Med Chem 2001;8:1467-86. |
| 3. | Unnati S, Ripal S, Sanjeev A, Niyati A. Novel anticancer agents from plant sources. Chin J Nat Med 2013;11:16-23. |
| 4. | Demain AL, Vaishnav P. Natural products for cancer chemotherapy. Microb Biotech 2011;4:687-99. |
| 5. | Mani RK, Kavitha K, Singh JD, Thakore P. A brief review of plants having anticancer property. Int J Pharm Res Dev 2012;3:129-36. |
| 6. | Li F, Li S, Li HB, Deng GF, Ling WH, Wu S, et al. Antiproliferative activity of peels, pulps and seeds of 61 fruits. J Funct Foods 2013;5:1298-309. |
| 7. | Wang X, Wei Y, Yuan S, Liu G, Zhang YL, Wang W. Potential anticancer activity of litchi fruit pericarp extract against hepatocellular carcinoma in vitro and in vivo. Cancer Lett 2006;239:144-50. |
| 8. | Bhanot A, Sharma R, Noolvi MN. Natural sources as potential anti-cancer agents: A review. Int J Phytomed 2011;3:9-26. |
| 9. | Kim H, Moon JY, Kim H, Lee DS, Cho M, Choi HK, et al. Antioxidant and antiproliferative activities of mango ( Magnifera indica L.) flesh and peel. Food Chem 2010;121:429-36. |
| 10. | Zhao M, Yang B, Wang J, Liu Y, Yu L, Jiang Y. Immunomodulatory and anticancer activities of flavonoids extracted from litchi ( Litchi chinensis Sonn) pericarp. Int Immunopharmacol 2007;7:162-6. |
| 11. | Prasad KN, Hao J, Shi J, Liu T, Li J, Wei X, et al. Antioxidant and anticancer activities of high pressure-assisted extract of longan ( Dimocarpus longan Lour.) fruit pericarp. Innov Food Sci Emerg 2009;10:413-9. |
| 12. | Manosroi J, Dhumtanom P, Manosroi A. Anti-proliferative activity of essential oil extracted from Thai medicinal plants on KB and P388 cell lines. Cancer Lett 2006;235:114-20. |
| 13. | Orhue PO, Momoh AR. Antibacterial activities of different solvent extracts of Carica papaya fruit parts on some gram positive and gram negative organisms. Int J Herbs Pharmacol Res 2013;2:42-7. |
| 14. | Arora M, Kaur P. Antimicrobial & antioxidant activity of orange pulp and peel. Int J Sci Res 2013;2:412-5. |
| 15. | Miller EG, Porter JL, Binnie WH, Guo IY, Hasegawa S. Further studies on the anticancer activity of citrus limonoids. J Agric Food Chem 2004;52:4908-12. |
| 16. | Okwu DE. Citrus fruits: A rich source of phytochemicals and their roles in human health. Int J Chem Sci 2008;6:451-71. |
| 17. | Rahmat A, Rosli R, Zain WN, Endrini S, Sani HA. Antiproliferative activity of pure lycopene compared to both extracted lycopenes and juices from watermelon ( Citrullus vulgaris) and papaya ( Carica papaya) on human breast and liver cancer cell lines. J Med Sci 2002;2:55-8. |
| 18. | Chen KC, Peng CC, Chiu WT, Cheng YT, Huang GT, Hsieh CL, et al. Action mechanism and signal pathways of Psidium guajava L. aqueous extract in killing prostate cancer LNCaP cells. Nutr Cancer 2010;62:260-70. |
| 19. | Fecht WJ Jr, Befeler AS. Hepatocellular carcinoma: Updates in primary prevention. Curr Gastroenterol Rep 2004;6:37-43. |
| 20. | Abu Bakar MF, Ahmad NE, Suleiman M, Rahmat A, Isha A. Garcinia dulcis fruit extract induced cytotoxicity and apoptosis in HepG2 liver cancer cell line. Biomed Res Int 2015;2015:916902. |
| 21. | Sun J, Chu YF, Wu X, Liu RH. Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem 2002;50:7449-54. |
| 22. | McDougall GJ, Ross HA, Ikeji M, Stewart D. Berry extracts exert different antiproliferative effects against cervical and colon cancer cells grown in vitro. J Agric Food Chem 2008;56:3016-23. |
| 23. | Ahmad N, Zawawy AE. Antioxidant, antitumor, antimicrobial studies and quantitative phytochemical estimation of ethanolic extracts of selected fruit peels. Int J Curr Microbiol Appl Sci 2015;4:298-309. |
| 24. | Kang KH. Citrus peel extract inhibits LPS-induced cytokines secretion in macrophage. Int J Biosci Biotechnol 2014;6:11-20. |
| 25. | Li ZY, Wang Y, Shen WT, Zhou P. Content determination of benzyl glucosinolate and anti-cancer activity of its hydrolysis product in Carica papaya L. Asian Pac J Trop Med 2012;5:231-3. |
| 26. | Iwase Y, Takemura Y, Ju-ichi M, Yano M, Ito C, Furukawa H, et al. Cancer chemopreventive activity of 3,5,6,7,8,3′,4′-heptamethoxyflavone from the peel of citrus plants. Cancer Lett 2001;163:7-9. |
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]
| This article has been cited by | | 1 |
Liposomes and phytosomes: Nanocarrier systems and their applications for the delivery of phytoconstituents |
|
| Yogesh Dutt, Ramendra Pati Pandey, Mamta Dutt, Archana Gupta, Arpana Vibhuti, V. Samuel Raj, Chung-Ming Chang, Anjali Priyadarshini | | Coordination Chemistry Reviews. 2023; 491: 215251 | | [Pubmed] | [DOI] | | | 2 |
Anatabine attenuates ovalbumin-induced asthma via oxidative stress and inflammation mitigation and Nrf2/HO-1 signaling upregulation in rats |
|
| Walied Abdo, Imer Haziri, Mohamed Dmerdash, Sulaiman Mohammed Alnasser, Ali Hakamy, Ehab Ali, Soha A. Soliman, Hanan H. Abd-Elhafeez, Ahmed M. Abd-Eldayem | | Life Sciences. 2022; : 120954 | | [Pubmed] | [DOI] | | | 3 |
Pharmacological Potentials and Nutritional Values of Tropical and Subtropical
Fruits of India: Emphasis on their Anticancer Bioactive Components |
|
| Arunaksharan Narayanankutty | | Recent Patents on Anti-Cancer Drug Discovery. 2022; 17(2): 124 | | [Pubmed] | [DOI] | | | 4 |
Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression |
|
| Saurabh Satija, Harpreet Kaur, Murtaza M. Tambuwala, Prabal Sharma, Manish Vyas, Navneet Khurana, Neha Sharma, Hamid A. Bakshi, Nitin B. Charbe, Flavia C. Zacconi, Alaa A. Aljabali, Srinivas Nammi, Harish Dureja, Thakur G. Singh, Gaurav Gupta, Daljeet S. Dhanjal, Kamal Dua, Dinesh K. Chellappan, Meenu Mehta | | Current Molecular Pharmacology. 2021; 14(3): 321 | | [Pubmed] | [DOI] | | | 5 |
Formulation, Characterisation and In vitro Cytotoxic Effect of Lens culinaris Medikus Seeds Extract Loaded Chitosan Microspheres |
|
| Kripi Vohra, Meenu Mehta, Vandana Garg, Kamal Dua, Harish Dureja | | Current Molecular Pharmacology. 2021; 14(3): 448 | | [Pubmed] | [DOI] | | | 6 |
Targeting Cancer using Curcumin Encapsulated Vesicular Drug Delivery Systems |
|
| Joel Hardwick, Jack Taylor, Meenu Mehta, Saurabh Satija, Keshav R. Paudel, Philip M. Hansbro, Dinesh K. Chellappan, Mary Bebawy, Kamal Dua | | Current Pharmaceutical Design. 2021; 27(1): 2 | | [Pubmed] | [DOI] | | | 7 |
Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives |
|
| Meenu Mehta, Saurabh Satija, Keshav R Paudel, Vamshikrishna Malyla, Vinod Kumar Kannaujiya, Dinesh Kumar Chellappan, Mary Bebawy, Philip M Hansbro, Peter R Wich, Kamal Dua | | Nanomedicine: Nanotechnology, Biology and Medicine. 2021; 31: 102303 | | [Pubmed] | [DOI] | | | 8 |
Applications of Nanocarriers as Drug Delivery Vehicles for Active Phytoconstituents |
|
| Phui Qi Ng, Laura Soon Cheau Ling, Jestin Chellian, Thiagarajan Madheswaran, Jithendra Panneerselvam, Anil Philip Kunnath, Gaurav Gupta, Saurabh Satija, Meenu Mehta, Philip Michael Hansbro, Trudi Collet, Kamal Dua, Dinesh Kumar Chellappan | | Current Pharmaceutical Design. 2020; 26(36): 4580 | | [Pubmed] | [DOI] | | | 9 |
Development of a novel HPTLC fingerprint method for simultaneous estimation of berberine and rutin in medicinal plants and their pharmaceutical preparations followed by its application in antioxidant assay |
|
| Saurabh Satija, Murtaza M. Tambuwala, Kavita Pabreja, Hamid A. Bakshi, Dinesh Kumar Chellappan, Alaa A. Aljabali, Srinivas Nammi, Thakur Gurjeet Singh, Harish Dureja, Gaurav Gupta, Kamal Dua, Meenu Mehta, Munish Garg | | JPC – Journal of Planar Chromatography – Modern TLC. 2020; 33(3): 313 | | [Pubmed] | [DOI] | | | 10 |
Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update |
|
| Meenu Mehta, Daljeet S. Dhanjal, Keshav R. Paudel, Bhupender Singh, Gaurav Gupta, S. Rajeshkumar, Lakshmi Thangavelu, Murtaza M. Tambuwala, Hamid A. Bakshi, Dinesh K. Chellappan, Parijat Pandey, Harish Dureja, Nitin B. Charbe, Sachin K. Singh, Shakti D. Shukla, Srinivas Nammi, Alaa A. Aljabali, Peter R. Wich, Philip M. Hansbro, Saurabh Satija, Kamal Dua | | Inflammopharmacology. 2020; 28(4): 795 | | [Pubmed] | [DOI] | | | 11 |
Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective |
|
| Parteek Prasher, Mousmee Sharma, Meenu Mehta, Keshav R. Paudel, Saurabh Satija, Dinesh K. Chellappan, Harish Dureja, Gaurav Gupta, Murtaza M. Tambuwala, Poonam Negi, Peter R. Wich, Nicole G. Hansbro, Philip M. Hansbro, Kamal Dua | | Chemico-Biological Interactions. 2020; 325: 109125 | | [Pubmed] | [DOI] | | | 12 |
Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics |
|
| Yoke Ying Tan, Pui Khee Yap, Griselda Loo Xin Lim, Meenu Mehta, Yinghan Chan, Sin Wi Ng, Deepak N. Kapoor, Poonam Negi, Krishnan Anand, Sachin Kumar Singh, Niraj Kumar Jha, Lay Cheng Lim, Thiagarajan Madheswaran, Saurabh Satija, Gaurav Gupta, Kamal Dua, Dinesh Kumar Chellappan | | Chemico-Biological Interactions. 2020; 329: 109221 | | [Pubmed] | [DOI] | | | 13 |
Advancing of Cellular Signaling Pathways in Respiratory Diseases Using Nanocarrier Based Drug Delivery Systems |
|
| Meenu Mehta, Daljeet Singh Dhanjal, Saurabh Satija, Ridhima Wadhwa, Keshav Raj Paudel, Dinesh Kumar Chellappan, Shiva Mohammad, Mehra Haghi, Philip M. Hansbro, Kamal Dua | | Current Pharmaceutical Design. 2020; 26(42): 5380 | | [Pubmed] | [DOI] | | | 14 |
Antiproliferative effects of boswellic acid-loaded chitosan nanoparticles on human lung cancer cell line A549 |
|
| Neeta Solanki, Meenu Mehta, Dinesh Kumar Chellappan, Gaurav Gupta, Nicole G Hansbro, Murtaza M Tambuwala, Alaa AA Aljabali, Keshav Raj Paudel, Gang Liu, Saurabh Satija, Philip M Hansbro, Kamal Dua, Harish Dureja | | Future Medicinal Chemistry. 2020; 12(22): 2019 | | [Pubmed] | [DOI] | | | 15 |
In vitro studies of glucose concentrations for Cell viability in normal and cancer cells |
|
| MOUNICA RAJU DANTULURI, ANIMISHA MOKKAPATI, RADHAKRISHNA NAGUMANTRI, SATYANARAYANA RENTALA | | International Journal of Pharma and Bio Sciences. 2018; 9(3) | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
